GLP-1s fail to slow progression of Alzheimer’s: Novo Nordisk

Nov 26, 2025 - 00:00

1

GLP-1s fail to slow progression of Alzheimer’s: Novo Nordisk

The trials showed an effect on Alzheimer's biomarkers, though Novo did not specify which ones.

Related Posts

ProPublica Documentary “Before A Breath” Streaming March 20

ProPublica Documentary “Before A Breath” Streaming Marc...

Mar 21, 2025 0

How a Push to Amend the Constitution Could Help Trump Expand Presidential Power

How a Push to Amend the Constitution Could Help Trump E...

Mar 21, 2025 5

Trump Halted an Agent Orange Cleanup. That Puts Hundreds of Thousands at Risk for Poisoning.

Trump Halted an Agent Orange Cleanup. That Puts Hundred...

Mar 21, 2025 4

Inside the Schools Alaska Ignored

Inside the Schools Alaska Ignored

Mar 21, 2025 2

How Texas Conservatives Use At-Large School Board Elections to Influence What Students Learn

How Texas Conservatives Use At-Large School Board Elect...

Mar 21, 2025 1

Curious How Trump’s Cost Cutting Could Affect Your National Park Visit? You Might Not Get a Straight Answer.

Curious How Trump’s Cost Cutting Could Affect Your Nati...

Mar 21, 2025 1